📰 Peter Choo News
Peter Choo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Choo. Real-time updates on events, politics, business and more.
January 29, 2024
29.01.2024 - The Company now has exclusive rights to a Malaysia, US and China patentSINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) - CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on ... Seite 1
November 17, 2023
Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited , a Singapore-based biopharmaceutical company focused on...
November 17, 2023
Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced its first half of 2023 financial results...
October 29, 2023
Kenpo Karate is one of the most effective offshoots of Karate that has been developed. Known for its practicality and adaptability to be used in self-defense
October 24, 2023
SINGAPORE / ACCESSWIRE / October 24, 2023 / CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "the Company"), a Singapore biopharmaceutical company focused on utilizing its licensed proprietary
October 24, 2023
CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing ...
September 25, 2023
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced that its exclusively licensed induced pluripotent stem cell (iPSC)-based technology has been granted a patent by the China National Intellectual Property Administration (CNIPA).
September 25, 2023
(RTTNews) - CytoMed Therapeutics Limited (GDTC) said its exclusively licensed induced pluripotent stem cell-based technology has been granted a pa...
August 15, 2023
/PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its...